Immunovant Ownership | Who Owns Immunovant?
Immunovant Ownership Summary
Immunovant is owned by 53.69% institutional investors, 55.64% insiders. Fmr is the largest institutional shareholder, holding 7.59% of IMVT shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.15% of its assets in Immunovant shares.
IMVT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immunovant | 53.69% | 55.64% | -9.34% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 10.48M | 7.59% | $276.77M |
| Vanguard group | 6.51M | 4.71% | $171.86M |
| Blackrock | 4.92M | 3.56% | $129.79M |
| Armistice capital | 3.40M | 2.46% | $89.68M |
| Deep track capital, lp | 2.88M | 2.09% | $76.13M |
| State street | 2.72M | 1.97% | $71.78M |
| Viking global investors lp | 2.32M | 1.68% | $61.27M |
| Alpine global management | 1.91M | 1.38% | $50.36M |
| Woodline partners lp | 1.82M | 1.32% | $48.14M |
| T. rowe price investment management | 1.63M | 1.18% | $42.91M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Alpine global management | 1.91M | 8.76% | $50.36M |
| Tyro capital management | 250.62K | 3.00% | $6.62M |
| Two seas capital lp | 692.41K | 2.97% | $18.28M |
| Prosight management, lp | 325.00K | 2.56% | $8.58M |
| Adar1 capital management | 476.54K | 2.38% | $12.58M |
| Deep track capital, lp | 2.88M | 2.27% | $76.13M |
| Paradigm biocapital advisors lp | 1.36M | 1.38% | $35.98M |
| Logos global management lp | 575.00K | 1.22% | $15.18M |
| Redmile group | 720.18K | 1.15% | $19.01M |
| Boxer capital | 825.00K | 1.15% | $21.78M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 10.48M | 0.02% | 2.83M |
| Deep track capital, lp | 2.88M | 2.27% | 2.39M |
| T. rowe price investment management | 1.63M | 0.03% | 1.63M |
| Armistice capital | 3.40M | 1.13% | 1.23M |
| Norges bank | 601.86K | 0.00% | 601.86K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | - | - | -1.38M |
| Logos global management lp | 575.00K | 1.22% | -1.20M |
| State street | 2.72M | 0.00% | -922.95K |
| Commodore capital lp | - | - | -750.99K |
| First turn management | - | - | -695.43K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| T. rowe price investment management | 1.63M | 0.03% | 1.63M | $42.91M |
| Norges bank | 601.86K | 0.00% | 601.86K | $15.89M |
| Canada pension plan investment board | 199.80K | 0.01% | 199.80K | $5.27M |
| Alps advisors | 113.93K | 0.02% | 113.93K | $3.01M |
| Mirae asset global etfs | 32.96K | 0.00% | 32.96K | $867.92K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -11.00 |
| Cibc private wealth group | -17.00 |
| Innealta capital | -59.00 |
| Principal securities | -70.00 |
| Barclays | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 204 | -4.23% | 78,645,357 | 5.27% | 53 | 2.05% | 94 | -14.55% | 64 | - |
| Jun 30, 2024 | 211 | -10.21% | 74,707,025 | 7.20% | 54 | 2.33% | 109 | 0.93% | 63 | -23.17% |
| Mar 31, 2024 | 235 | -7.11% | 69,688,195 | 1.94% | 48 | 2.16% | 108 | -20.00% | 82 | 3.80% |
| Dec 31, 2023 | 253 | 18.22% | 68,360,172 | 2.16% | 47 | 1.80% | 135 | 1.50% | 79 | 71.74% |
| Sep 30, 2023 | 214 | 36.31% | 66,916,900 | 20.66% | 51 | 2.53% | 133 | 49.44% | 46 | 4.55% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 4.62M | 3.15% | 164.70K |
| Fidelity Growth Compy Commingled Pl O | 4.45M | 3.04% | 196.00K |
| Fidelity Growth Company Fund | 3.38M | 2.31% | 98.83K |
| Vanguard Total Stock Mkt Idx Inv | 2.10M | 1.43% | -14.65K |
| SPDR® S&P Biotech ETF | 1.68M | 1.15% | 18.58K |
| Vanguard Small Cap Index | 1.65M | 1.13% | 3.25K |
| iShares Russell 2000 ETF | 1.50M | 1.02% | -3.37K |
| T. Rowe Price US Small-Cap Core Equity | 1.29M | 0.88% | 1.29M |
| T. Rowe Price Small-Cap Stock | 1.29M | 0.88% | 1.29M |
| Fidelity Growth Company K6 | 1.13M | 0.77% | 16.37K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 23, 2024 | Levine Mark S. | Chief Legal Officer | Sell | $128.78K |
| Oct 23, 2024 | Geffner Michael | Chief Medical Officer | Sell | $94.17K |
| Oct 23, 2024 | Stout Jay S | Chief Technology Officer | Sell | $80.91K |
| Oct 16, 2024 | Salzmann Peter | Chief Executive Officer | Sell | $261.85K |
| Oct 16, 2024 | Macias William L. | Chief Medical Officer | Sell | $75.63K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 10 |
| 2024 Q3 | - | 28 |
| 2024 Q2 | - | 23 |
| 2024 Q1 | - | 14 |
| 2023 Q4 | 1 | 26 |
IMVT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools